Sign inGet started

Goodrich Katherine

Insider CIK 2044770 · TARS Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
TARS Tarsus Pharmaceuticals, In A Award deriv2026-06-252026-06-293,837— $03,837SEC↗
TARS Tarsus Pharmaceuticals, In A Award deriv2026-06-252026-06-292,417— $02,417SEC↗
TARS Tarsus Pharmaceuticals, In S Sale2026-06-152026-06-172,954$62.08 $183.4K2,233SEC↗
TARS Tarsus Pharmaceuticals, In M Exercise deriv2026-06-122026-06-162,954— $00SEC↗
TARS Tarsus Pharmaceuticals, In M Exercise2026-06-122026-06-162,954— $05,187SEC↗
TARS Tarsus Pharmaceuticals, In M Exercise deriv2025-12-152026-01-142,233— $04,467SEC↗
TARS Tarsus Pharmaceuticals, In M Exercise2025-12-152026-01-142,233— $02,233SEC↗
TARS Tarsus Pharmaceuticals, In A Award deriv2025-06-122025-06-162,954— $02,954SEC↗
TARS Tarsus Pharmaceuticals, In A Award deriv2025-06-122025-06-164,540— $04,540SEC↗
TARS Tarsus Pharmaceuticals, In A Award deriv2024-11-132024-11-1510,000— $010,000SEC↗
TARS Tarsus Pharmaceuticals, In A Award deriv2024-11-132024-11-156,700— $06,700SEC↗